preclinical testing

Home>Tag:preclinical testing
May 23 2023

Halberd Initial Preclinical Testing Phase at Mississippi State University (MSU) Complete

By |2023-05-22T20:43:29-04:00May 23rd, 2023|Featured, Investor News, Press Releases|0 Comments

MSU is ahead of schedule and continues testing program Jackson Center, PA May 23, 2023 – Halberd Corporation (OTC-PINK: "HALB”) announced Mississippi State University (MSU) has completed the initial phase of its preclinical model to establish baseline testing parameters and study endpoints for Halberd's groundbreaking patent-pending nasal spray.  The nasal spray is designed to eliminate ...

Apr 11 2023

Halberd Begins Preclinical Testing at Mississippi State University (MSU)

By |2023-04-11T08:01:10-04:00April 11th, 2023|Featured, Investor News, News|0 Comments

Jackson Center, PA April 11, 2023 – Halberd Corporation (OTC-PINK: "HALB”) has announced that preclinical testing is now underway at Mississippi State University (MSU) for its groundbreaking patent-pending nasal spray designed to suppress the negative effects of Traumatic Brain Injury (TBI). This innovative research involves the development of test mechanisms by MSU's staff to quantify ...

Go to Top